Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Accumulated Expenses (2020 - 2025)

NeuroPace has reported Accumulated Expenses over the past 6 years, most recently at $13.3 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $13.3 million for Q4 2025, up 36.29% from a year ago — trailing twelve months through Dec 2025 was $13.3 million (up 36.29% YoY), and the annual figure for FY2025 was $13.3 million, up 36.29%.
  • Accumulated Expenses for Q4 2025 was $13.3 million at NeuroPace, up from $12.3 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for NPCE hit a ceiling of $13.3 million in Q4 2025 and a floor of $3.7 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $7.8 million (2021), compared with a mean of $8.4 million.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 87.73% in 2022 and later dropped 12.46% in 2024.
  • NeuroPace's Accumulated Expenses stood at $7.9 million in 2021, then fell by 6.42% to $7.4 million in 2022, then soared by 50.8% to $11.2 million in 2023, then decreased by 12.46% to $9.8 million in 2024, then skyrocketed by 36.29% to $13.3 million in 2025.
  • The last three reported values for Accumulated Expenses were $13.3 million (Q4 2025), $12.3 million (Q3 2025), and $9.7 million (Q2 2025) per Business Quant data.